BCX BCX
Company Profile ↓Company Overview
BCX (BCX) is a publicly traded company listed on with a market capitalization of $914.09M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 24.4%, reflecting efficient use of shareholder capital.
Net profit has compounded at 16.0% per year over the last five years.
Revenue has grown at a 15.4% CAGR over the past five years.
Maintains a net profit margin of 99.6%.
Carries low leverage with a debt-to-equity ratio of 0.02.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $215.74M (-968.4% YoY); net profit $214.79M.
- 5-Year Trend Long-term compounding — revenue CAGR 15.4%, profit CAGR 16.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 15.45% |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | 16.03% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +34.45% |
| 6 Months: | -2.07% |
| 3 Months: | -2.76% |
| 1 Month: | +3.81% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)61.30 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 24.4%.
- Excellent profit margin of 99.6%.
- Compounding revenue at 15.4% over 5 years.
- Profit CAGR of 16.0% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 140.21M | -6.36M | -24.84M | 215.74M |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 2.70M | 2.28M | 2.01M | 762.19K |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | - | 2.85K | 2.07K | 6.37K |
| Pretax Income | - | 137.51M | -8.64M | -26.86M | 214.79M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | 137.51M | -8.64M | -26.86M | 214.79M |
| Diluted EPS | 2.24 | 1.57 | -0.04 | -0.35 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 992.21M | 908.71M | 774.59M | 885.67M |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 39.40K | 11.24K | 71.34K | 17.41K |
| Inventory | - | - | - | - | - |
| Receivables | - | 6.76M | 1.67M | 1.20M | 2.75M |
| Total Liabilities | - | 9.03M | 17.37M | 6.03M | 5.65M |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Total Debt | 185.94K | 117.58K | - | 152.06K | - |
| Total Equity | - | 983.18M | 891.34M | 768.57M | 880.02M |
| Shares Outstanding | - | 87.52M | 84.36M | 80.20M | 76.24M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 55.14M | 84.14M | 95.82M | 103.20M |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | - | -55.43M | -84.19M | -95.76M | -103.26M |
| Capital Expenditure | - | - | - | - | - |
| Free Cash Flow | - | 55.14M | 84.14M | 95.82M | 103.20M |
| Net Change in Cash | - | -287.88K | -58.15K | 60.37K | -55.82K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 98.1% | 135.8% | 108.1% | 99.6% |
| ROE % | - | 14.0% | -1.0% | -3.5% | 24.4% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BCX
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
NEW YORK, July 31, 2026--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend …
BCX — Frequently Asked Questions
What is the current share price of BCX?
As of 2026-08-05 17:25 PDT, BCX trades at $11.99 on NASDAQ/NYSE. Its 52-week range is $8.86 to $13.25.
What is the market capitalisation of BCX?
BCX has a market capitalisation of $914.09M on NASDAQ/NYSE.
What is the P/E ratio of BCX?
BCX trades at a trailing price-to-earnings (P/E) ratio of -34.26. Its price-to-book (P/B) ratio is 1.04.
What is the return on equity (ROE) of BCX?
BCX has a return on equity (ROE) of 24.41%.
Is BCX a good stock to buy?
This page provides a data-driven analysis of BCX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.